Company: TAK
Filing Date: 2025-06-25
Form Type: 20-F
Source: 0001395064-25-000095
Chunk: 148

Company: TAKEDA PHARMACEUTICAL CO LTD
Filing Date: 2025-06-25
Form: 20-F
Item: Item 6
Chunk 148
---
      289                                                               Takeda Pharmaceutical Company Limited          59 (13)                                                            —                                   151 (14)       79 (14)                           

_____________

Notes:

(1) Compensation expense related to Performance Share Unit awards and Restricted Stock Unit awards are recognized over multiple fiscal years, depending on the length of the period eligible for earning compensation. This column shows amounts recognized as expenses during the fiscal year ended March 31, 2025.

(2) Shows the salary and annual bonus earned as Head of Global Business of Takeda Pharmaceuticals U. S. A., Inc.

(3) Basic compensation includes the grossed-up amount paid for residence and pension allowances etc. for the relevant officer (JPY 117 million).

(4) The amount recognized as an expense during the fiscal year for the stock incentive plan (Board Incentive Plan) grants awarded in fiscal years 2021-2024.

(5) The amount recognized as an expense during the fiscal year for the stock incentive plan (the Long-Term Incentive Plan for Company Group Employees Overseas (LTIP)) grants awarded in fiscal years 2023-2024.

(6) Shows the salary and other amounts earned as the President, Research and Development of Takeda Development Center Americas, Inc.

(7) The amount recognized as an expense during the fiscal year for the stock incentive plan (the Long-Term Incentive Plan for Company Group Employees Overseas (LTIP)) grants awarded in fiscal years 2021-2024.

(8) Amounts of local retirement plan contributions and other additional benefits paid by Takeda Development Center Americas, Inc. during the fiscal year, as well as the amount equal to taxes on such amounts.

(9) Compensation granted to or earned by Milano Furuta before appointment as a Director is not included.

(10) Basic compensation includes the amount paid for pension allowance etc. for the relevant officer. (JPY 5 million)

(11) The amount recognized as an expense during the fiscal year for the stock incentive plan (Board Incentive Plan) grants awarded in fiscal year 2024.

(12) Costa Saroukos retired at the close of 148th General Meeting of Shareholders held on June 26, 2024.

(13) Basic compensation includes the grossed-up amount paid for residence, pension allowances, and educational allowances etc. for the relevant officer. (JPY 25 million).

(14) The amount recognized as an expense during the fiscal year